B-lown away by our first CDP rating
April 13, 2023 | Agency life, CDP, Carbon, ESG, Environment, Sustainability
A catch up with Louise Jones, Cuttsy+Cuttsy’s sustainability officer, on what was achieved in 2022, the agency’s latest environmental assessment with CDP and a look ahead to 2023.
2022 was the year of COP27, extreme weather, and global climate reparations, and one in which Cuttsy+Cuttsy have been furthering their own efforts to become a more sustainable company. At the end of her first year as our sustainability officer at Cuttsy+Cuttsy, we catch up with Louise Jones on how much was achieved, their latest environmental assessment and a look ahead to 2023.
So, Lou, how was 2022?
2022 was a big year for us in the sustainability arena. I was appointed into the new role of sustainability officer, and we set about putting our Environmental, Social and Governance (ESG) strategy into place. We got off to a great start with a silver rating from EcoVadis. One of our principal goals for the year was to complete a voluntary disclosure with the Carbon Disclosure Protocol (CDP), which we submitted in July 2022. CDP is a not-for-profit charity that runs a global disclosure system to provide companies (as well as investors, cities, states, and regions) with a rating for their environmental performance.
Why CDP?
It’s important to know exactly where you’re starting from, before you can get a clear sight of where you need to go. And that’s where CDP comes in. CDP submission takes the form of a detailed questionnaire, designed to assess a company’s environmental management and progress towards stewardship. A company’s disclosure via CDP marks a starting point for improving good environmental management. This means striving to operate in line with a 1.5-degree, deforestation-free and water-secure future.
And was this all straight forward?
Despite our determination to base our ESG targets on real data through disclosures such as CDP and Science Based Targets Initiative, the submission was still pretty daunting. Not only did we need comprehensive information on our own environmental management and protection, but that of our entire supply chain, including Scope 3. However, we were determined to disclose by July to gain our first score by the end of 2022. Together with some support and advice from our sustainability consultant (David Masters, Ecofiniti) we gathered, analysed and submitted all the information possible.
That must have been a relief — what rating did you hope to achieve?
We had been advised to temper our hopes for our first CDP rating due to the complexity of the submission and difficulty of gaining a high rating straight off the bat. But just before we left for our Christmas break, we received a big, bright, bouncing B-rating, which we are still amazed and delighted about!
That sounds impressive, but what does it mean?
A B-rating is awarded to companies that have addressed the environmental impacts of their business and ensure good environmental management. This is a great point to build from. To achieve the very best CDP rating of A, we now need to look towards ‘undertaking actions that mark us out as a leader in [our] field’. As we focus on reaching Cuttsy+Cuttsy’s 2024 goal of Net Zero, aiming towards an A rating will be part of how we structure our approach.
On a personal level, when I see headlines about the government approving a new coal mine, I struggle to understand if we are all on the same page. I fear not. But when you are not happy about something taking action is vital — I guess it’s ‘about being the change you want to see’.
What’s next for 2023?
Our sustainability journey is still in its infancy and there are still plenty of learning curves to come. But we don’t view this negatively, as within everyone’s individual lives if we make a conscious and consistent effort to make changes, we are on the right track. That’s why this year we won’t be taking our foot of the gas when it comes to our ESG commitments. 2023 —watch this space!
References:
This content was provided by Cuttsy + Cuttsy
Company Details
Latest Content from Cuttsy + Cuttsy
Cuttsy+Cuttsy achieves Platinum accreditation from Investors in People
Cuttsy+Cuttsy is proud to have achieved a Platinum accreditation from Investors in People, placing them among the top 2% of organisations assessed globally.
Cuttsy+Cuttsy awarded Gold EcoVadis sustainability rating
Cuttsy+Cuttsy proudly announces their Gold Medal achievement from EcoVadis for 2024, placing them among the top 5% of companies assessed and within the 97th percentile, a testament to their unwavering...
Age is not just a number when it comes to clinical trials
In this blog we look at the critical underrepresentation of older adults in clinical trials, emphasising the need for inclusive trial designs and targeted strategies to ensure safe and effective...
How to boost clinical trial access and make patients health-empowered
Clinical research is becoming more patient-centric, but there's still more that needs to be done to make clinical trials available to everyone. This could include wider participation.
Closing the loop: Why clinical trial results matter to participants
Discover why sharing clinical trial results with participants is crucial for respect, informed health decisions, and fostering strong researcher-participant partnerships.
Unveiling the truth: A journey into women’s representation in clinical trials
We explore the historical exclusion of women from clinical trials, its consequences on medical research and treatment efficacy and the ongoing efforts to ensure their representation.
Clarity in clinical trials
Discover how transparent, empathetic communication and health literacy principles can empower patients and enhance engagement in clinical trials, transforming participants into active partners in their healthcare journey.
Caring for patients’ mental health in clinical trials
We look at why ensuring continuous mental health support for patients in clinical trials is essential to enhance their overall well-being and trial engagement.
Driving equitable healthcare: The role of DE&I in clinical trials
Diversity, equity and inclusion (DE&I) is becoming a bigger topic of conversation and meaningful action within clinical trials. And for good reason, too. Find out why we embrace this and...
Empowering patients through more accessible clinical trial information
Senior Medical Writer, Scott Palmer explores the challenges and solutions in enhancing patient engagement in clinical trials, from the pivotal role of healthcare professionals, to the importance of user-friendly trial...